[ad_1]
D.A. Davidson raised its Kellanova price target, ascribing a 50% likelihood of Mars acquiring the Pringles maker.
[ad_2]
Source link
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March...